WO2008066729A3 - Boronic acid containing compositions - Google Patents

Boronic acid containing compositions Download PDF

Info

Publication number
WO2008066729A3
WO2008066729A3 PCT/US2007/024173 US2007024173W WO2008066729A3 WO 2008066729 A3 WO2008066729 A3 WO 2008066729A3 US 2007024173 W US2007024173 W US 2007024173W WO 2008066729 A3 WO2008066729 A3 WO 2008066729A3
Authority
WO
WIPO (PCT)
Prior art keywords
boronic acid
acid containing
containing compositions
potency
manufacturing
Prior art date
Application number
PCT/US2007/024173
Other languages
French (fr)
Other versions
WO2008066729A2 (en
Inventor
Michael A Tyo
Original Assignee
Dara Biosciences Inc
Michael A Tyo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dara Biosciences Inc, Michael A Tyo filed Critical Dara Biosciences Inc
Publication of WO2008066729A2 publication Critical patent/WO2008066729A2/en
Publication of WO2008066729A3 publication Critical patent/WO2008066729A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides clinical grade compositions comprising peptide boronic acids, and methods of manufacturing the same to avoid degradation and maintain stability and potency.
PCT/US2007/024173 2006-11-22 2007-11-19 Boronic acid containing compositions WO2008066729A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86068606P 2006-11-22 2006-11-22
US60/860,686 2006-11-22

Publications (2)

Publication Number Publication Date
WO2008066729A2 WO2008066729A2 (en) 2008-06-05
WO2008066729A3 true WO2008066729A3 (en) 2008-09-25

Family

ID=39468462

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/024173 WO2008066729A2 (en) 2006-11-22 2007-11-19 Boronic acid containing compositions

Country Status (1)

Country Link
WO (1) WO2008066729A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104478912A (en) * 2014-12-20 2015-04-01 成都安斯利生物医药有限公司 Method for preparing saturated potassium azacyclo-trifluoroborates
RU2711380C2 (en) * 2015-07-16 2020-01-16 Байоксэл Терапьютикс, Инк. New approach to treating cancer with application of immunomodulation
CN110452258B (en) * 2019-09-03 2021-01-01 上海馨远医药科技有限公司 Preparation method of dipeptide valine boron proline salt
CN111537622B (en) * 2019-11-29 2021-11-26 杭州华东医药集团新药研究院有限公司 Method for detecting impurities of duloxetine and salts thereof
CN114113402B (en) * 2021-12-03 2023-05-23 重庆医药高等专科学校 Method for measuring pinanediol content in bortezomib by adopting high performance liquid chromatography

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GIBSON ET AL.: "A Practical Synthesis of L-Valyl-pyrrolidine-(2R)-boronic Acid: Efficient Recycling of the Costly Chiral Auxiliary (+)-Pinanediol", ORGANIC PROCESS RESEARCH & DEVELOPMENT, vol. 6, 2002, pages 814 - 816, XP009075554 *
ICHIKAWA ET AL.: "HPLC Determination of (+)-Pseudoephedrine and (-)-Ephedrine in Japanese Herbal Medicines Containing Ephedra Herb Using Solid-Phase Extraction", CHEM. PHARM. BULL., vol. 51, 2003, pages 635 - 639 *
LACROIX ET AL.: "Fenofibrate raw materials: HPLC methods for assay and purity and an NMR method for purity", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, vol. 18, 1998, pages 383 - 402 *

Also Published As

Publication number Publication date
WO2008066729A2 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
WO2008132229A3 (en) Highly concentrated insulin solutions and compositions
WO2008094558A3 (en) Stable s-(+)-abscisic acid liquid and soluble granule formulations
WO2007112940A3 (en) Albumin-derived amino acid sequence, use thereof for increasing the half-life of therapeutic proteins and of other therapeutic compounds and entities, and constructs comprising the same
WO2006117217A3 (en) Novel use of spiegelmers
WO2007125103A3 (en) Benzamide glucokinase activators
IL200407A0 (en) Stable digestive enzyme compositions, methods of producing the same and uses thereof
GEP20156328B (en) Solid pharmaceutical compositions and processes for their production
EP2039366A4 (en) Composition containing peptide as the active ingredient
WO2009055568A3 (en) Liposomal vancomycin formulations
WO2009017840A9 (en) Protein and isolated or purified amino acid product containing compositions and uses thereof
WO2007061939A3 (en) Metabolite derivatives of the hdac inhibitor fk228
WO2010048275A3 (en) Lyophilized recombinant vwf formulations
WO2008042686A3 (en) Multifunctional carriers for the delivery of nucleic acids and methods of use thereof
WO2010043717A3 (en) Pharmaceutical topical compositions
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
WO2008053297A3 (en) Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa
WO2007025146A3 (en) Balsalazide formulations and manufacture and use thereof
WO2009125409A3 (en) Fatty acid amides and uses thereof
WO2009115084A3 (en) Pyrrolopyrimidine derivatives, and use thereof
WO2009100275A3 (en) Compositions and devices
WO2009064366A3 (en) Methods and compositions for protein labeling using lipoic acid ligases
WO2008066729A3 (en) Boronic acid containing compositions
WO2011069037A3 (en) Stabilization and storage of biological pharmaceutical compositions
WO2008049920A3 (en) Il-21 variants
WO2007095661A8 (en) Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07867532

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07867532

Country of ref document: EP

Kind code of ref document: A2